These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
643 related articles for article (PubMed ID: 17151277)
41. The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer's disease. Dickson TC; Vickers JC Neuroscience; 2001; 105(1):99-107. PubMed ID: 11483304 [TBL] [Abstract][Full Text] [Related]
42. Relationship between apolipoprotein E and the amyloid deposits and dystrophic neurites of Alzheimer's disease. Dickson TC; Saunders HL; Vickers JC Neuropathol Appl Neurobiol; 1997 Dec; 23(6):483-91. PubMed ID: 9460714 [TBL] [Abstract][Full Text] [Related]
43. Parallel age-associated changes in brain and plasma neuronal pentraxin receptor levels in a transgenic APP/PS1 rat model of Alzheimer's disease. Bilousova T; Taylor K; Emirzian A; Gylys R; Frautschy SA; Cole GM; Teng E Neurobiol Dis; 2015 Feb; 74():32-40. PubMed ID: 25449907 [TBL] [Abstract][Full Text] [Related]
44. The regulation of p53 up-regulated modulator of apoptosis by JNK/c-Jun pathway in β-amyloid-induced neuron death. Akhter R; Sanphui P; Das H; Saha P; Biswas SC J Neurochem; 2015 Sep; 134(6):1091-103. PubMed ID: 25891762 [TBL] [Abstract][Full Text] [Related]
45. NP1 regulates neuronal activity-dependent accumulation of BAX in mitochondria and mitochondrial dynamics. Clayton KB; Podlesniy P; Figueiro-Silva J; López-Doménech G; Benitez L; Enguita M; Abad MA; Soriano E; Trullas R J Neurosci; 2012 Jan; 32(4):1453-66. PubMed ID: 22279230 [TBL] [Abstract][Full Text] [Related]
46. Accumulation of saposin in dystrophic neurites is linked to impaired lysosomal functions in Alzheimer's disease brains. Sharoar MG; Palko S; Ge Y; Saido TC; Yan R Mol Neurodegener; 2021 Jul; 16(1):45. PubMed ID: 34215298 [TBL] [Abstract][Full Text] [Related]
47. Co-localization of amyloid beta and tau pathology in Alzheimer's disease synaptosomes. Fein JA; Sokolow S; Miller CA; Vinters HV; Yang F; Cole GM; Gylys KH Am J Pathol; 2008 Jun; 172(6):1683-92. PubMed ID: 18467692 [TBL] [Abstract][Full Text] [Related]
48. p75NTR ectodomain is a physiological neuroprotective molecule against amyloid-beta toxicity in the brain of Alzheimer's disease. Yao XQ; Jiao SS; Saadipour K; Zeng F; Wang QH; Zhu C; Shen LL; Zeng GH; Liang CR; Wang J; Liu YH; Hou HY; Xu X; Su YP; Fan XT; Xiao HL; Lue LF; Zeng YQ; Giunta B; Zhong JH; Walker DG; Zhou HD; Tan J; Zhou XF; Wang YJ Mol Psychiatry; 2015 Nov; 20(11):1301-10. PubMed ID: 25917367 [TBL] [Abstract][Full Text] [Related]
49. The Arctic AβPP mutation leads to Alzheimer's disease pathology with highly variable topographic deposition of differentially truncated Aβ. Kalimo H; Lalowski M; Bogdanovic N; Philipson O; Bird TD; Nochlin D; Schellenberg GD; Brundin R; Olofsson T; Soliymani R; Baumann M; Wirths O; Bayer TA; Nilsson LN; Basun H; Lannfelt L; Ingelsson M Acta Neuropathol Commun; 2013 Sep; 1():60. PubMed ID: 24252272 [TBL] [Abstract][Full Text] [Related]
50. Amyloid precursor protein cytoplasmic domain with phospho-Thr668 accumulates in Alzheimer's disease and its transgenic models: a role to mediate interaction of Abeta and tau. Shin RW; Ogino K; Shimabuku A; Taki T; Nakashima H; Ishihara T; Kitamoto T Acta Neuropathol; 2007 Jun; 113(6):627-36. PubMed ID: 17431643 [TBL] [Abstract][Full Text] [Related]
52. Presenilin-1 mutations reduce cytoskeletal association, deregulate neurite growth, and potentiate neuronal dystrophy and tau phosphorylation. Pigino G; Pelsman A; Mori H; Busciglio J J Neurosci; 2001 Feb; 21(3):834-42. PubMed ID: 11157069 [TBL] [Abstract][Full Text] [Related]
53. Inositol trisphosphate 3-kinase B is increased in human Alzheimer brain and exacerbates mouse Alzheimer pathology. Stygelbout V; Leroy K; Pouillon V; Ando K; D'Amico E; Jia Y; Luo HR; Duyckaerts C; Erneux C; Schurmans S; Brion JP Brain; 2014 Feb; 137(Pt 2):537-52. PubMed ID: 24401760 [TBL] [Abstract][Full Text] [Related]
54. Lack of BACE1 S-palmitoylation reduces amyloid burden and mitigates memory deficits in transgenic mouse models of Alzheimer's disease. Andrew RJ; Fernandez CG; Stanley M; Jiang H; Nguyen P; Rice RC; Buggia-Prévot V; De Rossi P; Vetrivel KS; Lamb R; Argemi A; Allaert ES; Rathbun EM; Krause SV; Wagner SL; Parent AT; Holtzman DM; Thinakaran G Proc Natl Acad Sci U S A; 2017 Nov; 114(45):E9665-E9674. PubMed ID: 29078331 [TBL] [Abstract][Full Text] [Related]
55. [Alzheimer disease: cellular and molecular aspects]. Octave JN Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248 [TBL] [Abstract][Full Text] [Related]
56. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice. van Groen T; Kiliaan AJ; Kadish I Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076 [TBL] [Abstract][Full Text] [Related]
57. Neuronal and microglial involvement in beta-amyloid protein deposition in Alzheimer's disease. Cras P; Kawai M; Siedlak S; Mulvihill P; Gambetti P; Lowery D; Gonzalez-DeWhitt P; Greenberg B; Perry G Am J Pathol; 1990 Aug; 137(2):241-6. PubMed ID: 2117395 [TBL] [Abstract][Full Text] [Related]
58. [Potential involvement of abnormal increased SUMO-1 in modulation of the formation of Alzheimer's disease senile plaques and neuritic dystrophy in APP/PS1 transgenic mice]. Zhao XY; Wang DD; Shan Y; Zhu CQ Sheng Li Xue Bao; 2013 Jun; 65(3):253-62. PubMed ID: 23788181 [TBL] [Abstract][Full Text] [Related]
59. Neuronal pentraxin 1: a novel mediator of hypoxic-ischemic injury in neonatal brain. Hossain MA; Russell JC; O'Brien R; Laterra J J Neurosci; 2004 Apr; 24(17):4187-96. PubMed ID: 15115814 [TBL] [Abstract][Full Text] [Related]
60. Neuronal transcriptome, tau and synapse loss in Alzheimer's knock-in mice require prion protein. Stoner A; Fu L; Nicholson L; Zheng C; Toyonaga T; Spurrier J; Laird W; Cai Z; Strittmatter SM Alzheimers Res Ther; 2023 Nov; 15(1):201. PubMed ID: 37968719 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]